
usd pm et
summari provid precis instrument analyt servic softwar use life scienc
industri retail applic
price-to-earnings oper ep
think benefit industri geograph
product diversif spread across life scienc
industri retail end-market help firm
maintain stabl cash flow one end-market
may experienc short-term weak view
also benefit strong reput product
qualiti innov custom servic softwar
integr think contribut sticki
custom also low leverag rel
peer averag see posit partial off-set
increas relianc life scienc industri china
sale growth
fiscal year end dec ep estim base cfra
oper earn histor earn report
cash dividend paid last year
past perform indic futur perform reli upon
analysi prepar equiti analyst
pm stock trade
sale grew yoy led
laboratori product total revenu
increas sale strong lab
sale driven robust demand
research custom life scienc
expect continu new
applic industri
gene-bas therapi immuno-oncolog
continu rapidli develop
also see robust demand growth
china drove sale growth
asia/rest world geographi outpac
growth rate america
europ respect
encourag abil pass
tariff-rel price increas china
custom without loss sale momentum
materi outpac year
revenu growth reduc sg
ratio basi point cost save
initi also continu invest new
technolog
think drive continu sale growth
margin improv adjust pre-tax
margin
worthi premium valuat
view due excel price power driven
high switch cost deriv
integr labx softwar
cutting-edg precis instrument
expect share outperform market
next year howev think
fulli valu recent forward price-to-earnings near
averag
think price power evidenc
upward trend adjust pre-tax margin
without
major period competit
advantag also appar adjust pre-tax
return invest capit
consist think lead
industri expect strong return continu
futur year continu invest
 maintain technolog leadership
target
ep estim -- long-term
forward price-to-earnings averag expect life scienc
custom continu drive above-averag
growth risk view includ potenti
govern restrict sale growth
china slowdown biopharmaceut
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview mettler-toledo intern inc suppli precis measur
analysi instrument servic use laboratori sale industri food retail
applic product servic critic custom life scienc industri
pharmaceut biotech compani well contract research organ food beverag
produc chemic specialti chemic cosmet compani food retail transport
logist industri metal industri electron industri academ commun
compani report oper five segment oper sale swiss
oper western european oper chines oper
product sever key product categori includ balanc pipett laboratori softwar
detail
laboratori balanc compani manufactur broad varieti laboratori balanc associ
analysi instrument weigh rang one ten-millionth gram kilogram
laboratori balanc primarili use pharmaceut biotechnolog test lab food chemic
cosmet academia industri
pipett pipett use laboratori dispens precis volum liquid compani
also maintain servic center key market custom period send pipett
certifi recalibr princip end market pipett pharmaceut biotech academia
analyt instrument product segment includ titrat measur chemic composit
sampl use environment research laboratori well qualiti control lab
pharmaceut food beverag industri thermal analysi system measur
materi properti function temperatur weight dimens energi flow viscoelast
properti use primarili plastic polym industri academia increasingli
pharmaceut industri ph meter densiti refractometri insrument moistur analyz
laboratori softwar labx compani pc-base laboratori embed softwar platform manag
analyz data gener balanc titrat ph meter moistur analyz
analyt instrument labx provid full network capabl assist workflow autom
enabl custom collect archiv data complianc food drug administr
fda traceabl requir electron store data
believ labx softwar largest market share analyt instrument softwar
packag research engin familiar labx high level integr laboratori
workflow make custom sticki view switch new instrument run
unfamiliar softwar would requir extens train costli effort updat workflow
industri weigh instrument offer comprehens line industri scale weigh
devic bench scale floor scale weigh modul weigh load gram
sever thousand kilogram industri weigh product use wide rang industri
applic count formul mix ingredi qualiti control
industri termin transport logist vehicl scale system softwar industri
termin allow collect data integr manufactur process help autom
also suppli automat dimension measur data captur solut integr
in-mot weigh dimens identif technolog solut custom
measur weight cubic volum packag appropri bill load manag qualiti
control also produc scale weigh truck railcar heavi industri scale capabl
measur weight ton permit accur weigh extrem environment condit
also provid softwar integr industri analysi product improv
workflow enhanc data collect analysi
corpor strategi histor highli acquisit like life scienc peer
period spent million acquisit versu averag
billion larg peer life scienc tool servic industri like thermo fisher agil
made two rel small acquisit last three year howev juli
compani acquir henri troemmer million novemb acquir biotix
million -base manufactur distributor plastic consum associ
pipett includ tip tube reagent reservoir use life scienc market
typic make limit small-scal acquisit prolif purchas share
compani made net repurchas impact share issuanc total
billion repurchas reduc share count three-year period
provid materi boost ep activ repurchas share price declin
view think indic manag adept term capit alloc
financi trend sale increas billion billion repres
three-year compound annual growth rate compound-annual-growth-rate period adjust pre-tax incom
per share grown three-year compound-annual-growth-rate earn growth outpac sale growth due
share repurchas well adjust pre-tax incom margin improv
indic excel price power view conserv capit
ebita-to-interest decemb
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli overvalu usd
bullish sinc januari technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
posit fundament outlook
lst sub-industri
next month think among
fastest-grow sub-industri within health
care sector driver earn growth
sub-industri next year
view strong growth public fund
health care research increas
spend biopharmaceut compani
budget nation institut
nih grew rapidli last three year
materi increas fund academ
govern lab turn drive sale
growth lst compani gener
materi portion revenu lab
fy nih budget grew
fy
budget increas aid lst
sub-industri sale growth
forecast
expect anoth materi nih budget
increas fy support robust
demand sub-industri product
year ahead well
addit public-fund health care
research expect larg increas privat
biopharmaceut spend drive sale
growth life scienc tool servic
sub-industri month end septemb
estim spend
increas year-over-year
spend biotech
depart research tool product
well contract research servic
 growth continu year ahead
translat continu solid sale growth
lst sub-industri
care research type prolifer
around world particularli china
emerg market turn
drive strong intern sale growth
establish life scienc tool servic
compani china particular
view howev tailwind may moder
china face slowdown econom
growth use five largest compani
lst sub-industri proxi estim
averag growth sub-industri
china-deriv sale slow
year-over-year
long-term though think china
major emerg market nation like india
need continu rapidli increas health care
expenditur parallel grow
middl class turn like continu
support strong sale growth lst
sub-industri see happen despit
potenti neg impact
import/export tariff limit
large-scal supplier option
state-of-the-art lst product outsid
compani notabl except
switzerland-bas roch
 life
rise
 life
drop
base index
five-year market price perform
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
analyst research note compani news
inc keep target
peer ep estim base
market leadership sever end market ep vs ahead
estim sale includ fx benefit rose sale rose
north america asia declin europ due partli tough
compar growth last year along time holiday
expect improv sale growth europ come quarter lab sale
account total sale rose industri account
sale declin food retail sale flat industri sale
advers impact declin product inspect sale account
industri sale howev believ trend product inspect
focus food manufactur pharmaceut product remain posit
anticip improv sale growth next sever quarter /jeffrey
intern buy hold keep target
ep estim peer near
high end five-year rang set ep
ep vs ahead view sale rose lab
sale industri food retail remain soft fall
see solid above-industry-averag sale note tough compar
china particularli yet see modest improv food retail
believ field turbo spinnak sale program continu yield
et cfra keep hold opinion share mettler toledo
rais target peer
forward ep estim ep vs
ahead estim rais ep estim
sale rose driven robust growth asia
america europ grew moder lab sale rose
industri rose food retail smallest unit fell
field turbo sale initi continu drive sale via faster replac
cycl enabl gain market share view /jeffrey loo cfa
pm et cfra lower view mettler-toledo intern inc share
hold buy maintain ep estim
target price ep estim -- higher
long-term forward price-to-earnings averag see life scienc custom drive
above-averag futur growth underli fundament busi
remain strong lower opinion hold approxim
ytd return move share price valuat rang view
fairli valu last five year share trade averag
forward price-to-earnings multipl respect share
valu consensu ep estim think
expens side even consid grow price power instrument
softwar custom view increasingli sticki
typic direct free cash flow share repurchas
elev valuat repurchas diminish posit impact
ep growth /colin scarola
et cfra keep buy opinion share
intern inc lift target
ep estim -- long-term forward price-to-earnings
averag see life scienc drive above-averag futur growth ep
vs beat consensu rais ep estim
start grew sale yoy organ
growth local currenc notabl despit new tariff sale growth china
remain robust yoy drove acceler growth asia
region sale yoy yoy
encourag abil pass tariff-rel price increas
custom without loss momentum think speak strength
brand lack meaning competit market like china oper
continu improv well sg yoy despit strong sale
growth price power oper effici continu worthi
rel high valuat view /colin scarola
inc keep target
ep estim long-term averag forward price-to-earnings
see life scienc custom fuel above-averag futur growth ep
vs ahead consensu rais ep estim
maintain grew sale yoy
yoy local currenc sale growth led lab product
revenu yoy local currenc robust demand growth
lab product come research custom life scienc industri
expect continu biotech industri particular
continu expand also see steadi improv oper margin
continu
uniqu posit pass price increas custom view due
strength technolog relationship see attribut
worthi rel high valuat /colin scarola
keep target price peer
forward ep estim within five- year rang
ep vs ahead estim
rais ep estim ep estim
sale includ fx benefit rose
broad-bas across end-market geographi sale grow
america europ asia/rest world biotix
acquisit contribut sale growth sale china also grew
howev estim tariff china implement trump
administr advers impact earn
inclus addit tariff announc juli yet
implement made suppli chain adjust rais
off-set impact tariff first half /jeffrey loo cfa
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd fiscal year analyst estim
earn per share grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
